Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) is a personalized treatment giving hope to patients diagnosed with various lymphomas. Receiving CAR-T cell therapy can take a few weeks as a patient's T cells, which normally help fight off infections, are collected and genetically engineered to target lymphoma.
____________________________________________
FOR THE PUBLIC: More health and medical news on the Mayo Clinic News Network. [ Ссылка ]

FOR THE MEDIA ONLY: Register at [ Ссылка ]... to access clean and nat sound versions of this video on the Mayo Clinic News Network. [ Ссылка ]

Mayo Clinic [ Ссылка ] Follow Mayo Clinic on Instagram: [ Ссылка ] Like Mayo Clinic on Facebook: [ Ссылка ] Follow Mayo Clinic on Twitter: [ Ссылка ]

свернуть